抗发作药物的认知作用在中叶中
Cedric Dusanter1, Marion Houot2,3,4, Marie Mere1
1Department of Neurology, Epileptology Unit, Reference Center for Rare Epilepsies, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
European journal of neurology
|August 31, 2023
概括
抗发作药物 (ASM) 显著影响患者的认知能力. 托皮拉和烯酸显示有害影响,而其他具有特定的认知影响,指导更安全的药物选择.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 临床神经学 临床神经学
背景情况:
- 抗发作药物 (ASM) 的认知影响是复杂的,需要进一步研究.
- 了解这些影响对于优化治疗和患者生活质量至关重要.
研究的目的:
- 评估ASM对同质患者群体认知功能的影响.
- 为临床医生提供指导,帮助他们选择具有良好的认知特征的ASM.
主要方法:
- 对287名患有耐火性中叶和海马硬化症的患者进行了回顾性分析.
- 认知评估包括全球性,口头和绩效智商,记忆力,执行功能和语言.
- 在认知得分和ASM类型,数量,剂量,生成和不可修改因素之间进行了相关联.
主要成果:
- 抗发作药物显著影响认知,总数和特定药物是关键因素.
- 托皮拉 (TPM) 和甲 (VPA) 显示出整体有害的认知效应.
- 卡巴马泽平和尼萨米德对特定的认知领域产生负面影响,例如口头记忆和语言.
结论:
- ASM对的认知功能有很大的影响.
- 建议减少ASM的数量,避免那些具有不利认知特征的ASM.
- 临床医生在开处方ASM时应考虑认知副作用,以优化患者的治疗结果.
更多相关视频
相关概念视频
Antiepileptic Drugs: Calcium Channel Blockers
446
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
446
Antiepileptic Drugs: Sodium Channel Blockers
658
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
658
Antiepileptic Drugs: Glutamate Antagonists
418
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
418
Antiepileptic Drugs: GABAergic Pathway Potentiators
453
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
453
Antiepileptic Drugs: Potassium Channel Activators
210
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
210
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
341
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
341


